Leviceta 250 mg (Tablet)

Unit Price: ৳ 16.00 (3 x 10: ৳ 480.00)

Strip Price: ৳ 160.00

Medicine Details

Category	Details
Generic	Levetiracetam
Company	General pharmaceuticals ltd
Also available as	Leviceta 500 mg tablet Leviceta 500 mg oral solution

Indications

Monotherapy for partial-onset seizures in adults and adolescents
Adjunctive therapy for partial-onset seizures in adults, adolescents, children, and infants
Treatment of myoclonic seizures in adults and adolescents
Treatment of primary generalized tonic-clonic seizures in adults and adolescents

Description

Unknown precise mechanism of antiepileptic effect, minimal activity in submaximal stimulation, inhibition of burst firing in epileptiform activity, prevention of hyper synchronization of seizure activity

Dosage

Recommended starting dose for adults and adolescents
Dosing recommendations for pediatric population
Tablet formulation not adapted for use in infants and children under 6 years

Administration

Oral administration, to be taken with sufficient quantity of liquid, administered in two equally divided doses

Interaction

No influence on serum concentrations of existing antiepileptic medicinal products
Inhibition of renal clearance of primary metabolite by probenecid
Concomitant administration with methotrexate may decrease methotrexate clearance
Isolated reports of decreased efficacy when administered with osmotic laxative
No alteration of absorption by food, slightly reduced rate of absorption

Contraindications

Hypersensitivity to active substance, pyrrolidone derivatives, or excipients

Side Effects

Most common adverse reactions in adult patients
Most common adverse reactions in pediatric patients

Pregnancy & Lactation

Not recommended during pregnancy, excreted in human breast milk, no impact on fertility in animal studies

Precautions & Warnings

Dose adjustment may be required for patients with renal impairment
Rare cases of decreased blood cell counts reported
Monitoring for signs of depression and suicidal ideation and behavior recommended
Tablet formulation not adapted for use in infants and children under 6 years

Use in Special Populations

Dose adjustment recommended in elderly patients with compromised renal function
Individualized daily dose for patients with renal impairment
No dose adjustment needed in patients with mild to moderate hepatic impairment

Overdose Effects

Observed effects of Leviceta overdoses
No specific antidote available
Symptomatic treatment may include haemodialysis

Therapeutic Class

Adjunct anti-epileptic drugs

Storage Conditions

Store at a cool temperature (not exceeding 25°C) and dry place, protected from light